Astrana Health, Inc. (ASTH)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $9.3M
- Jun 17 · Unusual
- Form 4 sales
- 34
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 salePlan not statedJun 8 2020
Sold 33,385 shares at $17.21 ($575k)
Vazquez Adrian, Chief Medical Officer
Sold 6.4% of holdings ($8.9M position)484,873 shares left0.6x usual sizeFiling
- 2 Form 4 salePlan not statedSep 9 +93 days
Sold 13,267 shares at $18.07 ($240k)
Vazquez Adrian, Chief Medical Officer
Sold 2.7% of holdings ($8.8M position)471,606 shares left0.2x usual sizeFiling
- 3 Form 4 salePlan not statedSep 11 +2 days
Sold 602 shares at $18.00 ($11k)
Vazquez Adrian, Chief Medical Officer
Sold 0.1% of holdings ($8.5M position)471,004 shares left0x usual sizeFiling
- 4 Form 4 salePlan not statedApr 1 +202 days
Sold 1.6M shares at $24.50 ($40.1M)
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp, 10% owner
Sold 13.3% of holdings ($301M position)10.7M shares leftFirst sale on recordFiling
- 5 Form 4 saleUnusualApr 28 +27 days
Sold 100,000 shares at $24.50 ($2.5M)
Vazquez Adrian, Chief Medical Officer
Sold 21.2% of holdings ($11.5M position)371,004 shares left4.3x usual sizeFiling
- 6 Form 4 salePlan not statedJun 15 +48 days
Sold 5,000 shares at $48.58 ($243k)
Young Albert WaiChow, Chief Administrative Officer
Sold 0.4% of holdings ($54.2M position)1.1M shares leftFirst sale on recordFiling
- 7 Form 4 saleUnusualAug 17 +63 days
Sold 40,000 shares at $73.67 ($2.9M)
Schmidt David, Director
Sold 100% of holdings ($2.9M position)0 shares leftFirst sale on recordFiling
- 8 Form 4 saleUnusualJun 17 +304 days
Sold 250,000 shares at $37.00 ($9.3M)
Marsh Linda, Director
Sold 48.1% of holdings ($19.2M position)270,081 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (34)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2022 | Marsh Linda | Director | Form 4 sale | 250,000 | $9.3M | 48.1% | Unusual | SEC |
| Aug 17, 2021 | Schmidt David | Director | Form 4 sale | 40,000 | $2.9M | 100.0% | Unusual | SEC |
| Jun 15, 2021 | Young Albert WaiChow | Chief Administrative Officer | Form 4 sale | 5,000 | $243k | 0.4% | Plan not stated | SEC |
| Apr 28, 2021 | Vazquez Adrian | Chief Medical Officer | Form 4 sale | 100,000 | $2.5M | 21.2% | Unusual | SEC |
| Apr 1, 2021 | ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp | 10% owner | Form 4 sale | 1.6M | $40.1M | 13.3% | Plan not stated | SEC |
| Sep 11, 2020 | Vazquez Adrian | Chief Medical Officer | Form 4 sale | 602 | $11k | 0.1% | Plan not stated | SEC |
| Sep 9, 2020 | Vazquez Adrian | Chief Medical Officer | Form 4 sale | 13,267 | $240k | 2.7% | Plan not stated | SEC |
| Jun 8, 2020 | Vazquez Adrian | Chief Medical Officer | Form 4 sale | 33,385 | $575k | 6.4% | Plan not stated | SEC |
| Jun 3, 2020 | Vazquez Adrian | Chief Medical Officer | Form 4 sale | 2,683 | $48k | 0.5% | Plan not stated | SEC |
| Sep 13, 2019 | Vazquez Adrian | Chief Medical Officer | Form 4 sale | 84,800 | $1.7M | 14.0% | Plan not stated | SEC |
| Jun 4, 2019 | Vazquez Adrian | Co-Chief Medical Officer | Form 4 sale | 85,000 | $1.4M | 12.3% | Plan not stated | SEC |
| Nov 28, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 35,000 | $581k | 6.3% | Plan not stated | SEC |
| Nov 27, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 50,000 | $878k | 8.2% | Plan not stated | SEC |
| Nov 23, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 50,000 | $828k | 7.6% | Plan not stated | SEC |
| Nov 21, 2018 | Vazquez Adrian | Co-Chief Medical Officer | Form 4 sale | 221,597 | $3.9M | 24.3% | Plan not stated | SEC |
| Nov 20, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 40,000 | $731k | 5.7% | Plan not stated | SEC |
| Sep 10, 2018 | Vazquez Adrian | Co-Chief Medical Officer | Form 4 sale | 33,574 | $512k | 3.5% | Plan not stated | SEC |
| Aug 30, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 22,900 | $365k | 3.2% | Plan not stated | SEC |
| Aug 28, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 30,000 | $510k | 4.0% | Plan not stated | SEC |
| Aug 27, 2018 | Vazquez Adrian | Co-Chief Medical Officer | Form 4 sale | 25,000 | $434k | 2.6% | Plan not stated | SEC |
| Aug 24, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 33,000 | $535k | 4.2% | Plan not stated | SEC |
| Aug 22, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 30,000 | $496k | 3.7% | Plan not stated | SEC |
| Aug 20, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 22,000 | $398k | 2.6% | Plan not stated | SEC |
| Jun 14, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 20,000 | $327k | 2.3% | Plan not stated | SEC |
| Jun 13, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 28,000 | $437k | 3.2% | Plan not stated | SEC |
| Jun 11, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 20,000 | $303k | 2.2% | Plan not stated | SEC |
| Jun 7, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 28,411 | $410k | 3.0% | Plan not stated | SEC |
| Jun 5, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 27,752 | $411k | 2.9% | Plan not stated | SEC |
| Jun 1, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 21,352 | $300k | 2.2% | Plan not stated | SEC |
| May 30, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 11,752 | $157k | 1.2% | Plan not stated | SEC |
| May 25, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 11,752 | $164k | 1.2% | Plan not stated | SEC |
| May 23, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 11,752 | $177k | 1.2% | Plan not stated | SEC |
| May 21, 2018 | Hosseinion Warren | Co-Chief Executive Officer | Form 4 sale | 11,752 | $185k | 1.1% | Plan not stated | SEC |
| Dec 12, 2012 | Augusta Gary | Director | Form 4 sale | 4,000 | $5k | 1.9% | Plan not stated | SEC |